Co-founded in 2017 by two pioneers in genome editing technology, Qihan Biotech has world-leading capabilities in multiplexable genome editing as well as vast experience in Immune shielding. We apply these tools in both human stem cells and animal germline cells to deliver novel immune-privileged cell and organ therapies.
Location: China, Zhejiang, Hangzhou City
Employees: 11-50
Total raised: $25.5M
Founded date: 2017
Investors 4
| Date | Name | Website |
| - | Alta Partn... | altapartne... |
| 08.11.2023 | ARCH Ventu... | archventur... |
| 09.02.2022 | Matrix Par... | matrixpart... |
| - | Northern L... | nlvc.com |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 23.09.2019 | Series A | $25.5M | - | dealstreet... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 26.09.2023 | Deals in brief: AnyMind Group acquires Indonesia-based DDI, ... | AnyMind Group acquires Digital Distribusi Indonesia The Singapore-founded brand enablement company ... | kr-asia.co... |
| 29.03.2021 | Qihan Biotech Raises Additional USD 67 Million in Series A++... | Qihan Biotechnology Co. Ltd (“Qihan” or “the Company”), a leader in applying multiplexable genome ed... | marketscre... |
| 29.03.2021 | China’s Qihan Biotech nets $67m funding from LAV, Sequoia, o... | Gene technology-focused Qihan Biotech on Monday said it has bagged as much as $67 million in its Ser... | dealstreet... |
| 29.03.2021 | China’s Qihan Biotech nets $67m funding from LAV, Sequoia, o... | Premium Gene technology-focused Qihan Biotech on Monday said it has bagged as much as $67 million i... | dealstreet... |
| 23.09.2019 | China’s gene-editing startup Qihan Biotech raises $25.5m in ... | Premium Chinese gene-editing technology developer Qihan Biotech announced on Monday that it has sec... | dealstreet... |